MedTech News
.................... by Andrew Celentano
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software
Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform.
Wearable smart patch could automatically deliver aid during a fentanyl overdose
A patch smaller than a penny could one day save the lives of people experiencing a fentanyl overdose—even when no one else is there to help.
New way to help CAR-T cells fight solid tumors could change cancer treatment
For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine. By reprogramming a patient’s own immune cells to attack cancer, doctors have produced remarkable results against certain blood cancers, offering hope to patients who once had few treatment options.
Two devices in one: Metasurface could bring medical imaging to smaller sensors
Researchers have developed a technology for building more compact point-of-care medical imaging devices by creating a material that acts as two devices in one.
Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™
BALTIMORE, Aug. 14, 2026 /PRNewswire/ — Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá.
High-speed microscopy reveals electrical activity across the brain
The new technique could help scientists learn how the entire brain works to generate decisions and emotions.
Drug that targets an inflammatory enzyme could help prevent lung cancer
A new study by MIT researchers shows that inhibiting caspase-1 can reduce the risk of tumor growth.
New mechanism may help predict and improve macrophage-targeted cancer immunotherapy
Immunotherapy that targets tumor-associated macrophages, a type of immune cell in the tumor microenvironment, works only if the cells have a functional system of molecules that enables them to respond to the treatment.